权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease

扩大医疗保险优惠覆盖范围对终末期肾病患者的影响

基本信息

批准号：
10435533
负责人：
AMAL N. TRIVEDI
金额：
$ 63.69万
依托单位：
BROWN UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-06-21 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10435533
关键词：
Address Admission activity Adopted American Caring Cessation of life Characteristics Clinical Communities Complex County Data Diagnosis Dialysis patients Dialysis procedure Disadvantaged End stage renal failure Enrollment Evaluation Face Geography Health Health Policy Health Services Accessibility Healthcare Hemodialysis Home Hospitalization Impairment Incentives Incidence Interview Kidney Kidney Diseases Kidney Failure Kidney Transplantation Low income Managed Care Managed Care Programs Medicare Methods Modeling Morbidity - disease rate Neighborhoods Nephrology Outcome Patient-Focused Outcomes Patients Peritoneal Dialysis Persons Policies Population Population Intervention Poverty Privatization Provider Quality of Care Quality of life Renal Replacement Therapy Risk Risk Factors Role Services Testing Time Transplantation United States Centers for Medicare and Medicaid Services Ursidae Family Variant Waiting Lists base beneficiary black patient bundled payment care outcomes community center cost design ethnic minority ethnic minority population experimental study falls health equity health outcome disparity hospital readmission improved improved outcome innovation insight living kidney donor mortality novel payment programs racial and ethnic racial disparity social social health determinants socioeconomics

项目摘要

Project Summary The over 500,000 Americans with dialysis-dependent kidney failure, also known as end-stage renal disease (ESRD), suffer from high mortality rates, severe morbidity, impaired quality of life, and frequent hospitalizations and readmissions. The burden of ESRD falls heavily on disadvantaged communities, with higher incidence rates and lower access to nephrology care among racial/ethnic minority populations and those living in high-poverty neighborhoods. Changes in coverage and payment financing policies in the Medicare program have had substantial consequences for access to care and health equity in the ESRD population. For instance, Medicare's decision in 1973 to extend coverage to Americans with irreversible kidney failure led to marked reductions in deaths due to kidney disease and decreased racial disparities in access to dialysis. Effective January 1, 2021, Medicare will open up enrollment of ESRD patients in private Medicare Advantage (MA) plans. Historically, persons with ESRD have been ineligible to join MA plans except under limited exceptions. Eighty-three thousand persons with ESRD (14% of Medicare's ESRD population) are projected to join an MA plan within two years. Unfortunately there is little evidence to guide policymakers about the consequences of managed care for persons with ESRD, variations across plans, and the implications for disparities in kidney health. More broadly, MA enrollment has more than quadrupled over the past 15 years, yet fundamental questions about the value of managed care for persons for serious health conditions remain answered. Our long-term objective is to understand the effects of payment and financing changes on the quality, equity, and outcomes of care for persons with ESRD. This mixed-methods study, the next step in our agenda, will investigate the impact of the Medicare program's expansion of MA enrollment to the ESRD population on dialysis care, hospitalizations and mortality. Our specific aims are: 1. Examine MA plans' approaches to managing care for persons with ESRD by conducting qualitative interviews with representatives from MA plans, dialysis organizations, and dialysis facility staff in geographically diverse markets. 2. Estimate the impact of expanding MA coverage to patients with ESRD on mode of kidney replacement therapy, hospitalizations and mortality. 3. Identify variations in the impact of Medicare Advantage on ESRD outcomes by patient and plan characteristics. The project is innovative because we leverage an unprecedented policy experiment in the Medicare program and the availability of plans across counties to derive causal estimates of the impact of managed care for dialysis patients. This project will have a positive impact by producing timely evidence about the role of MA plans in delivering care for persons with ESRD, a population with complex health needs and social risk factors. We address survival, hospitalizations, and the use of home dialysis, outcomes that have been prioritized by the nephrology community, the Medicare program, and the 2019 Executive Order on Advancing American Kidney Health.

项目总结